MACROGENICS INC (MGNX) › Cash & EquivalentsMACROGENICS INC (MGNX) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2010: $36.88M2011: $55.22M2012: $47.74M2013: $116.48M2014: $157.59M2015: $196.17M2016: $84.10M2017: $211.73M2018: $220.13M2019: $126.47M2020: $181.13M2021: $123.47M2022: $108.88M2023: $100.96M2024: $182.84M2025: $57.22M$57.22M2010Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$57.22M-68.7%2024$182.84M+81.1%2023$100.96M-7.3%2022$108.88M-11.8%2021$123.47M-31.8%2020$181.13M+43.2%2019$126.47M-42.5%2018$220.13M+4.0%2017$211.73M+151.8%2016$84.10M-57.1%2015$196.17M+24.5%2014$157.59M+35.3%2013$116.48M+144.0%2012$47.74M-13.5%2011$55.22M+49.7%2010$36.88M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share